Cite
MLA Citation
R. Balamurgan et al.. “IDF21-0338 Results of Randomized Double Blind Phase III trial of FDC of Remogliflozin Etabonate and Teneligliptin in T2DM patients.” Diabetes research and clinical practice, vol. 186, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100156441724.0x000038